Text or WhatsApp Richard at (808) 600-9260
Lion crestHealthcareInvestmentBanking.com

Buyer Due Diligence Checklist: What a PE Firm or Strategic Will Ask Your Practice

Buyers test eight workstreams: financials and quality of earnings, billing and coding, payer contracts, provider agreements, regulatory, HR, IT and HIPAA, and real estate. The first three carry most of the price risk because they feed adjusted EBITDA directly. Below are the 32 core requests that move price. If time is short, start with the QoE items (1 to 6) and the items that override the score (8, 13, 15, 20, 22 and 23). Each comes with the document that answers it and the red flag that turns it into a price cut. A scoring rule and a 90-day order of work follow.

Market growth does not tell you what a particular practice is worth. The checklist below is how a buyer decides that.

Data as of November 20, 2026. Each figure names its source and period where it appears. Worked examples use hypothetical practice figures and an assumed 8x EBITDA multiple, chosen for round arithmetic. The formula works at any multiple.

Who sends the request list

All three rows come from the same PESP dataset of 2025 PE-backed healthcare deals.

Buyer type Activity, source and population
PE add-on (bolt-on to a platform) 664 of the 1,029 PE-backed healthcare deals the Private Equity Stakeholder Project tracked in 2025, or 64.5% (our arithmetic) (PESP, 2025 in Review)
PE leveraged buyout 151 of the same 1,029 deals, or 14.7% (our arithmetic) (PESP)
PE growth investment 214 of the same 1,029 deals, or 20.8% (our arithmetic) (PESP)

PESP built its counts from PitchBook and LevinPro HC data and calls its 2025 totals an underestimate. Read the counts as a floor, not a full census. Hospital and health system buyers are left out of the table because Kaufman Hall, the main tracker, counts deals between hospitals and health systems, not practice purchases. Becker's Hospital Review, reporting Kaufman Hall's Q3 2026 data, describes 2026 hospital M&A as on pace for the busiest year since the pandemic. In Q3 2026 the average seller in those deals approached $586 million of annual revenue (Kaufman Hall, Q3 2026 report, October 13, 2026). The same report describes continued margin pressure across many hospitals, one reason a system buyer tends to underwrite your margin after integration, not before.

For most practice sellers the request list comes from a PE-owned platform. PESP's busiest PE healthcare subsectors in 2025, ranked by total deals of every type, were health IT (151), dental care (149), outpatient care (148), medtech (117) and behavioral health (56). In dental, 95% of the 149 deals were add-ons by PE-owned platforms, and 10 of the 18 platforms with the most deals were dental companies (PESP). In outpatient care, 119 of the 148 deals were add-ons (80.4%, our arithmetic). Dermatology led with 24 deals, then eye care with 22 and oncology with 9 (PESP data reported by Becker's ASC Review).

Where each buyer digs deepest

This table is an editorial summary of common patterns, not survey data. Individual buyers vary.

Workstream PE add-on buyer PE buyout sponsor Hospital, health system or corporate strategic
QoE Standardized, often the platform's own team Full third-party QoE Margin after integration
Coding Sample audit against platform norms External audit, deep sample Audit plus conversion to system billing
Payer contracts Rate comparison to platform contracts Durability and concentration Assignment to system contracts
Providers Retention and non-competes Retention, rollover, leadership bench Conversion to the buyer's employment model
Regulatory Checklist review Full structural review Full review plus state filings
Management Light. The platform supplies it Bench depth below the founders Fit with existing leadership

Upload and index every item below before the request list arrives. The healthcare data room checklist maps the 32 items to a folder structure. The healthcare M&A timeline shows where diligence falls between the LOI and close.

Table 1: Financial, QoE and billing requests (items 1 to 9)

# Item Why buyers care Document or proof Red flag
1 Monthly P&L and balance sheet, 36 months The QoE starts from reconciled numbers Monthly financials tied to tax returns and bank statements Book-to-tax gaps nobody can explain
2 EBITDA add-back schedule Price is set on adjusted EBITDA An invoice or ledger entry behind each add-back Personal expenses claimed with no paper trail
3 Normalized physician compensation Post-close pay replaces owner draws and resets EBITDA Current pay by provider and proposed post-close pay Model assumes owners will work for below-market pay
4 Revenue by payer, provider, site and CPT code Concentration and mix drive the multiple 36-month report from the practice management system One payer or one physician carries the practice
5 A/R aging and net collection rate Proves charges turn into cash A/R aging by payer, days in A/R Balances over 120 days carried at full value
6 Net working capital trend Sets the peg for the price adjustment Monthly NWC, 12 to 24 months A/R pulled forward or payables delayed before close
7 Rate exposure Buyers rerun revenue at the rates that apply after close Medicare volume by CPT priced at current Physician Fee Schedule rates, plus a list of commercial contracts tied to Medicare rates Forecast built on stale rates
8 External coding audit Overcoding becomes refund liability and lost EBITDA Independent sample audit, findings, remediation E/M levels skewed high against specialty peers
9 Overpayment and credit balance log Unrefunded money is a liability the buyer will escrow against Refund log, credit balance report, refund policy Old credit balances, identified overpayments not reported and returned promptly, or no written policy

Items 1 through 6 make up most of a sell-side QoE. Item 3 can move EBITDA in either direction.

Worked example: physician compensation (hypothetical, 8x, our arithmetic). An owner-physician draws $900,000 and market pay for the role is $650,000. The $250,000 difference is a valid add-back. $250,000 × 8 = $2.0 million of price. Flip it: the physician draws $400,000 against the same $650,000 market rate. The buyer deducts $250,000 from EBITDA and the price falls by the same $2.0 million.

Item 7 scales with your Medicare mix. Medicare spending grew 7.8% to $1,118.0 billion in 2024, 21% of all US health spending (CMS NHE fact sheet), and most practices carry a meaningful slice of it. Medicare lines reprice at the fee schedule in force. Commercial lines move only where the contract ties its rates to Medicare. Otherwise they follow their own terms and renewal dates. A cash-pay practice sees little movement. The QoE prep checklist covers each item in more depth.

Table 2: Payer contracts and provider agreements (items 10 to 17)

# Item Why buyers care Document or proof Red flag
10 Every commercial payer contract and fee schedule Rates and term decide how durable revenue is Executed contracts, amendments, current rate exhibits Rates confirmed only by email, or expired contracts
11 Change-of-control and assignment clauses Some contracts terminate or need consent on sale One-page clause summary per contract Top payer requires consent and the practice has no contact there
12 Medicare and Medicaid enrollment for every NPI and TIN Every provider must bill under the right enrollment after close PECOS records, reassignments, revalidation dates Providers billing under the wrong TIN
13 Physician employment agreements Post-close revenue depends on who stays Signed agreements, pay formulas, term and notice Pay formula tied to referrals
14 Non-competes and non-solicits Protect the goodwill being bought Signed covenants and an enforceability review Covenants unsigned or never updated
15 Medical director and contractor agreements Main source of referral-law exposure Signed agreements, fair market value support, time logs Expired agreements still being paid
16 Licensure and credentialing files Payers and buyers verify each provider License, DEA, board certification, malpractice history Lapsed license or a pending board action
17 Background checks and references on partners and leaders The buyer is underwriting the people Background reports and documented reference calls The buyer finds the history before you disclose it

Buyers read items 13 and 15 for referral risk. A pay formula that rewards referrals, or a medical director fee with no time logs and no fair market value opinion, gets treated as a structural problem, not a cleanup item. Rewrite the agreement with an FMV opinion behind it before launch.

On item 17, run the checks and reference calls on your own partners and administrator first. Court records, licensing board actions and exclusion lists are public, so a buyer can find them without your help. Anything your checks turn up belongs in your disclosure schedule, not the buyer's findings memo.

Table 3: Regulatory and ownership change (items 18 to 24)

# Item Why buyers care Document or proof Red flag
18 Medicare ownership change analysis Medicare treats a sale differently by provider type and deal structure Written analysis mapping the deal to the right Medicare process Nobody has asked the question
19 CMS enrollment filing plan Missed filings put billing privileges at risk Filing calendar tied to the target closing date Closing date set with no enrollment plan
20 HHA and hospice ownership history Buyers give these provider types added ownership-change scrutiny Initial enrollment date and every majority ownership change Recent enrollment or ownership change with no written review
21 OIG exclusion screening Billing for excluded staff creates repayment exposure LEIE screening logs for employees and contractors, at hire and on a set schedule No screening for contractors
22 Compliance program and audit history Shows whether problems get caught and fixed Compliance plan, training records, hotline log, payer audits, subpoenas Open payer audit left off the disclosure schedule
23 Clinical control and MSO structure Lay control of clinical decisions can break the model MSO agreement, governance documents, state review MSO sets clinical staffing or physician pay
24 Transaction notice analysis Any notice or review period sets the earliest closing date Written analysis of which transaction reviews apply Target close set before the analysis exists

On item 21, the screening cadence is a policy choice. Write it down and follow it, because the log is what the buyer reviews. On item 23, expect the buyer to read the MSO agreement clause by clause.

High-risk area: regulatory review. Rules vary by provider type, deal structure and state. This page is not legal advice. Questions to take to your own attorney:

  1. Does our deal structure trigger a Medicare ownership change process, and which one applies?
  2. Which enrollment filings are needed before or after close, and how could they affect billing?
  3. Do any of our provider types face added ownership-change review?
  4. Do our physician pay formulas, medical director fees or related-party leases raise referral-law concerns?
  5. Does our MSO structure keep clinical control with licensed physicians in every state where we operate?
  6. Could any transaction notice or review affect our timing or structure?
  7. What from our compliance and audit history belongs on the disclosure schedule?

Regulatory fact pack: what to hand your deal counsel in the first 30 days

Items 18 to 24 depend on facts only the practice holds. Deliver them in one package and the advisor hours you pay for go to analysis, not collection. Questions on physician pay, medical director fees, leases and MSO control belong with the healthcare compliance due diligence guide, and questions on closing-date reviews with the healthcare M&A process guide. This checklist is not a complete or jurisdiction-specific legal analysis. The rules vary by provider type, deal structure and state, so take the questions those pages raise to your own attorney.

Fact pack item What goes in it Internal owner Feeds items
Ownership chart Every entity, owner and percentage today, and the proposed chart after close, including rollover Managing partner 18, 19, 23, 24
Enrollment map Every NPI, TIN, reassignment and revalidation date, by site and provider Billing and revenue cycle lead 12, 18, 19
Site and provider-type list Every location, its state, the provider types at each, owned or leased Practice administrator 20, 23, 24, 31
Physician financial relationship register Every payment to or from a physician or a physician's family: pay, director fees, leases, loans, ownership stakes CFO or controller 13, 15, 31
MSO and management agreements Signed agreements, fee formula, governance documents, who approves staffing and physician pay Managing partner 23
Deal size estimate Headline price range and the buyer's approximate size, taken from the proceeds work below CFO or sell-side advisor 24
Compliance history Payer audits, subpoenas, refunds made, hotline log Practice administrator 21, 22
Target calendar Planned LOI, signing and closing dates Managing partner 19, 24

Before you send the pack, check it.

Ask for three outputs: a short written memo on each of items 18 to 24, an earliest realistic closing date, and a list of fixes to finish before launch. Those feed the disclosure schedule and the "fix before launch" table below. The healthcare compliance due diligence guide and the management services organizations guide give background on each area.

Table 4: HR, IT and HIPAA, and real estate (items 25 to 32)

# Item Why buyers care Document or proof Red flag
25 Employee census Payroll is the largest cost line Role, pay, FTE, tenure and benefits for every employee Key staff on undocumented pay deals
26 Wage and hour classification Misclassification creates back-pay liability Exempt status analysis and a contractor list Hourly roles paid as exempt
27 Benefit plans and retention arrangements Plan defects and promised bonuses carry over to the buyer Plan documents, filings, retention letters Verbal promises of equity or bonuses to staff
28 HIPAA security risk analysis Breach exposure follows the buyer Current written risk analysis and a remediation plan No written risk analysis on file
29 Incident log and business associate agreements Vendors holding PHI extend the exposure Incident and breach log, a signed BAA for every PHI vendor Billing or IT vendor with no BAA
30 EHR and PM system contracts Conversion cost and data access after close Contracts, term, exit fees, data export rights Auto-renewal past close with a large exit fee
31 Leases for every site Rent is a fixed cost and assignment needs consent Leases, amendments, estoppels, assignment clauses Related-party lease with no appraisal, or never put in writing
32 Owned real estate and sale-leaseback plans Valued apart from the operating business Appraisal, title, proposed lease terms Sale-leaseback planned with no FMV rent support

On item 25, buyers benchmark your pay scales against market. Check current regional wage data for your roles on the BLS Health Care and Social Assistance page before the buyer does. Use the latest annual release and note its reference period when you compare. Wage figures vary by role and region, so compare against the data for your own area. A staff member paid well under market is a retention risk the buyer will price.

A lease between the practice and a building its physicians own draws referral-law scrutiny. Put a current appraisal, FMV rent support and a signed lease on file before launch.

What a full request list adds

The 32 items are the requests that move price. A full buyer list also covers the workstreams below. They rarely cut the headline number on their own, but gaps here slow the close and widen indemnities.

Workstream Typical requests Red flag
Tax Three to five years of federal, state and payroll returns, entity tax elections, sales and use tax positions Missing election paperwork or unfiled state returns
Corporate records and capitalization Formation documents, operating or shareholder agreements, minutes, ownership ledger, prior equity promises Equity promised to a former partner and never documented
Litigation Every pending or threatened suit, board complaint, demand letter and settlement for five years Matters known to the owner but missing from the list
Insurance Malpractice policies and claims history, tail coverage plan, cyber, general liability, D&O No tail plan for claims-made malpractice coverage
Equipment and fixed assets Asset register, equipment leases and loans, maintenance records Leased imaging equipment listed as owned
Clinical quality Quality measures, patient complaints, peer review, accreditation and survey results Survey deficiencies with no plan of correction
Debt and liens Loan agreements, lines of credit, UCC lien search Liens that survive close without a payoff letter

Seven findings that cut the price after the LOI

The order is illustrative. It sorts findings by the purchase agreement tool that absorbs each one, starting with those that hit EBITDA or cash at close. It is not a measure of frequency or of typical dollar impact across deals. Dollar figures are hypothetical at 8x.

# Finding How the deal absorbs it Worked example (hypothetical, 8x, our arithmetic)
1 QoE EBITDA below marketed EBITDA Multiple applied to the lower number $4.0M marketed, $3.4M accepted. $0.6M × 8 = price falls $4.8M
2 Working capital below the peg Dollar-for-dollar adjustment at close Peg $1.20M, delivered $0.95M. Price falls $0.25M
3 Coding audit findings Refund reserve, special escrow or special indemnity on top of the general escrow Corrected coding lowers EBITDA $0.25M (× 8 = $2.0M) plus a $0.3M refund reserve. Total $2.3M
4 Payer concentration or consent risk Part of the price moves into an earnout or holdback One payer at 40% of revenue with a consent clause. A slice of price waits on consent
5 Physician departure risk More rollover, longer employment terms, retention-based consideration Two of five partners near retirement. Their share of revenue is priced on a contingent basis
6 Referral-linked pay or MSO control defects Pre-close restructuring and special indemnities Medical director paid on a referral-linked formula. Agreement rewritten and exposure carved out
7 Undisclosed litigation or investigations Trust damage first, then price, then other terms reopen A payer audit the buyer finds on its own reopens terms already agreed

Findings 1 to 3 hit EBITDA or cash at close directly. Finding 7 is the one sellers control completely. A matter you disclose early gets priced once. A matter the buyer finds on its own gets priced, then reopens every term that rested on trust.

Worked example: from headline price to cash at close (hypothetical, our arithmetic). Assumptions: 8x multiple applied to EBITDA to get headline price, $2.0M of debt paid off at close, a general escrow of 10% of headline price, rollover equity of 20% of headline price and $1.0M of transaction costs. The example applies findings 1 and 2 only.

Line As marketed After findings 1 and 2
EBITDA $4.0M $3.4M
Headline price at 8x $32.0M $27.2M
Less debt payoff ($2.0M) ($2.0M)
Less working capital shortfall $0 ($0.25M)
Less general escrow (10% of headline) ($3.2M) ($2.72M)
Less rollover equity (20% of headline) ($6.4M) ($5.44M)
Less transaction costs ($1.0M) ($1.0M)
Cash at close $19.4M $15.79M
Held back: escrow plus rollover $9.6M $8.16M
Total seller value, net of debt and costs $29.0M $23.95M

Total seller value falls $5.05M, which is the $4.8M headline cut plus the $0.25M working capital shortfall. Cash at close falls $3.61M. The other $1.44M comes out of escrow and rollover. Both are at risk, so a dollar there is worth less than a dollar of cash. Use the LOI red flags checklist to cap escrow and indemnity terms before exclusivity, and run your own numbers in the deal proceeds calculator.

Public market multiples frame the conversation about the multiple. They do not set it. Listed-company EV/EBITDA figures, such as those in Damodaran's NYU Stern dataset, describe far larger and more liquid companies, so they are a poor guide to a private practice's multiple. If a buyer cites them, check the current version of the file.

Private practice multiples are set deal by deal. Smaller size, payer concentration and physician dependence usually put them below listed-company levels. Every finding above works by lowering either the EBITDA or the multiple applied to it.

Fix before launch, or disclose

Not every red flag needs fixing before launch. Some cost less to disclose and price up front.

Situation Fix before launch Disclose and price
Referral-linked pay, expired medical director agreements, MSO control defects Yes. These force restructuring or special indemnities Not enough on their own
Unsupported add-backs Yes. Drop them or document them Never market an add-back you cannot prove
Coding errors found in your own audit Fix the process and refund overpayments Disclose the audit and remediation
Pending suit, board complaint or payer audit Cannot be fixed by the seller Always disclose, and early
Payer contract needing consent Open the payer conversation early Disclose and propose a consent plan
Partner near retirement Sign a transition or employment term Disclose and offer a retention structure
Missing BAAs, stale risk analysis Yes. Low cost, fast Not needed once fixed

Running the request list once it arrives

How you answer the list is itself diligence. Slow, partial or inconsistent answers read as weak controls.

Practice Why it works
One point of contact on the seller side Keeps answers consistent and stops staff from answering off the record
A shared tracker with every request, owner, due date and status Shows the buyer progress and exposes stalled items early
Answer in documents, not explanations A ledger entry beats an email describing one
Reconcile before you upload Revenue in the CPT report should tie to the P&L and the QoE
Batch follow-up questions weekly Cuts back-and-forth and keeps advisor hours down
Log every disclosure with the date it was made Settles later arguments over what the buyer knew at signing

Assign every item an internal owner before the list arrives.

Owner Items
CFO, controller or outside accountant 1, 2, 3, 5, 6, 9, 25, 27
Billing and revenue cycle lead 4, 7, 8, 12
Practice administrator 10, 11, 16, 21, 22, 26, 30, 31
Managing partner 13, 14, 15, 17, 23, 32
Compliance or IT lead 28, 29
Outside advisors, working from the fact pack 18, 19, 20, 24

If you hire a sell-side advisor to run the process, check the firm's track record and call references from recent sellers before you sign an engagement letter. FINRA BrokerCheck covers registered firms and individuals, but some M&A advisors work without broker registration and will not appear there.

Scoring rule: count the items you can prove today

Score one point for each of the 32 items where the document exists, is current and sits in an indexed data room folder a reviewer can open. A current document that sits outside the room scores zero today, and the fix is an upload, not a rebuild. Run a second count of documents that exist but are not yet filed. The gap between the two counts is your data room work. Everything else is remediation.

The cut-offs below are an editorial framework for sequencing work. They are not validated benchmarks, have not been tested against deal outcomes and should not be quoted as industry standards.

Score Open items Status Action
28 to 32 Four or fewer Ready for a process Close the gaps while the advisor builds the materials. Launch once the disclosure schedule is set
20 to 27 Five to twelve Fixable gaps Matches the scope of the 90-day plan below. Finish it before going to market
Under 20 Thirteen or more (over 40% of the list) Not ready Delay launch. Expect the buyer to hit most of the seven findings

A red flag on item 8, 13, 15, 20, 22 or 23 overrides the score. Each one can force a restructuring or a special indemnity on its own. Fix those before any buyer conversation.

30/60/90-day order of work

Days 1 to 30. Reconcile 36 months of financials to tax returns (item 1). Pull the payer, provider and CPT mix (item 4). Collect every payer contract and employment agreement (items 10 and 13). Run LEIE screening on all staff and contractors and write down the screening policy (item 21). Inventory every NPI, TIN and enrollment record (item 12). Order a UCC lien search and pull corporate records. Assemble the regulatory fact pack and deliver it.

Days 31 to 60. Commission an external coding audit (item 8) and a sell-side QoE (items 2, 3, 5 and 6). Reprice Medicare revenue at current fee schedule rates and flag commercial contracts tied to Medicare (item 7). Get FMV support for physician pay, medical director fees and related-party leases (items 13, 15 and 31). Complete or update the HIPAA risk analysis and BAAs (items 28 and 29). Confirm the malpractice tail plan.

Days 61 to 90. Close the fixes listed in the regulatory memos on items 18 to 24. Draft the disclosure schedule with every suit, audit and board matter. Complete background checks and reference calls (item 17). Load and index the data room, then rescore. The guide to preparing a healthcare company for sale and the healthcare M&A process guide show where this work fits in the full timeline.

Questions owners ask

How long does buyer due diligence take for a medical practice?

Three workstreams set the pace: the quality of earnings review, the coding audit and the regulatory review. The first two move as fast as your records allow. If your financials reconcile and your coding audit is already done, the buyer confirms that work instead of starting it. The regulatory review depends on deal size, structure, provider types and the states where the practice operates. Map it before the LOI. When the financial and coding work is finished before the LOI, the regulatory calendar usually sets the closing date.

How is the working capital peg set?

The peg is the normal level of net working capital the business needs to run, usually based on a trailing 12-month average of monthly NWC. At close, delivered working capital is compared to the peg and the price moves dollar for dollar. A shortfall of $250,000 cuts the price by $250,000. Negotiate the peg in the LOI with your own monthly NWC schedule in hand. Agree on how A/R is valued and which accounts count before exclusivity.

What triggers price chips most often after the LOI?

Three findings move the price most mechanically because they hit EBITDA or cash at close directly. This is an editorial view, not deal-level frequency data. They are a QoE that lands below the EBITDA in the marketing materials, net working capital that comes in under the peg, and coding audit findings that create refund liability. At an 8x multiple, every $100,000 of EBITDA the QoE rejects takes $800,000 off the headline price. Run your own QoE and coding audit first so you see these numbers before the buyer does.

Do PE firms and strategic buyers ask for different things?

The core request list is the same. Strategics put more weight on integration: system conversion, payer contract assignment and overlap with their existing sites. PE sponsors focus on standalone adjusted EBITDA, physician retention and whether the practice can support add-ons. Of the 1,029 PE-backed healthcare deals the Private Equity Stakeholder Project tracked in 2025, 664 were add-ons (64.5%, our arithmetic). Leveraged buyouts were 151 (14.7%) and growth investments were 214 (20.8%). In our editorial view, not survey data, a buyout sponsor usually runs the broadest review, while an add-on buyer often runs a shorter, standardized list focused on billing, payers and providers.

Sources